Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Objective Response Rate Description: To evaluate the efficacy of lifileucel as measured by ORR per RECIST v1.1 as assessed by the IRC Time frame: 5 years. After: Measure: Objective Response Rate Description: To evaluate the efficacy of lifileucel as measured by ORR per RECIST v1.1 as assessed by the investigators Time frame: 12 months.
Planned enrollment decreased by 76 participants
Before: 100 participants (planned). After: 24 participants (planned).
Primary completion date changed
Before: Dec 2032. After: Dec 2027.